10.27.11
OmniGuide Inc., a Cambridge, Mass.-based medical device company that develops optical scalpels for various types of surgical procedures, has named former Covidien executive Scott Flora as president and CEO. He also was named to the company's board.
Flora will assume his new role on Nov. 1, replacing OmniGuide founder Yoel Fink, who will remain as chairman while taking on the role of director of the Research Laboratory of Electronics at the Massachusetts Institute of Technology. Flora has more than 20 years of experience in the medical device sector, most recently serving as global business unit president of surgical devices at Covidien. Prior to Covidien, Flora spent 15 years at Smith & Nephew, including work as president and general manager of the orthopedics reconstruction business.
OmniGuide’s products are sold under the BeamPath brand. The core technology, based on an omnidirectional reflector was developed by MIT researchers, including Fink in 1998, and was licensed to OmniGuide in 2003. OmniGuide said its CO2 laser scalpels have been used in more than 25,000 surgical procedures in fields including neurosurgery, otolaryngology, gynecology, pulmonology and gastroenterology, the company reports.
In 2009, OmniGuide was one of 28 companies awarded $25 million in tax incentives by the Massachusetts Life Sciences Center, with OmniGuide receiving $540,000 in incentives. Earlier that year, OmniGuide reported that it had pulled in $1.8 million in an equity round, which was followed by a $25 million investment round in 2010.
Flora received a bachelor’s degree in marketing from Millikin University, and has completed executive programs at INSEAD, Wharton and Yale.
Flora will assume his new role on Nov. 1, replacing OmniGuide founder Yoel Fink, who will remain as chairman while taking on the role of director of the Research Laboratory of Electronics at the Massachusetts Institute of Technology. Flora has more than 20 years of experience in the medical device sector, most recently serving as global business unit president of surgical devices at Covidien. Prior to Covidien, Flora spent 15 years at Smith & Nephew, including work as president and general manager of the orthopedics reconstruction business.
OmniGuide’s products are sold under the BeamPath brand. The core technology, based on an omnidirectional reflector was developed by MIT researchers, including Fink in 1998, and was licensed to OmniGuide in 2003. OmniGuide said its CO2 laser scalpels have been used in more than 25,000 surgical procedures in fields including neurosurgery, otolaryngology, gynecology, pulmonology and gastroenterology, the company reports.
In 2009, OmniGuide was one of 28 companies awarded $25 million in tax incentives by the Massachusetts Life Sciences Center, with OmniGuide receiving $540,000 in incentives. Earlier that year, OmniGuide reported that it had pulled in $1.8 million in an equity round, which was followed by a $25 million investment round in 2010.
Flora received a bachelor’s degree in marketing from Millikin University, and has completed executive programs at INSEAD, Wharton and Yale.